Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Koenig

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Pharmaceutical Statistics|July 10, 2018
A proposal for a new PhD level curriculum on quantitative methods for drug developmentT Jaki, A Gordon, P Forster, et al.
Gut|May 13, 2003
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shuntB Angermayr, M Cejna, F Karnel, et al.
Clinical Pharmacology and Therapeutics|September 22, 2016
"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?H-G Eichler, B Bloechl-Daum, P Bauer, et al.
Frontiers in Immunology|March 3, 2020
Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 ImmunityRodrigo Jiménez-Saiz, Varun C Anipindi, Heather Galipeau, et al.
Frontiers in Pharmacology|August 8, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)M Karolyi, E Pawelka, S Omid, et al.
Science (New York, N.Y.)|January 5, 2019
Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreakL E Kafetzopoulou, S T Pullan, P Lemey, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Pharmaceutical Statistics|July 10, 2018
A proposal for a new PhD level curriculum on quantitative methods for drug developmentT Jaki, A Gordon, P Forster, et al.
Gut|May 13, 2003
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shuntB Angermayr, M Cejna, F Karnel, et al.
Clinical Pharmacology and Therapeutics|September 22, 2016
"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?H-G Eichler, B Bloechl-Daum, P Bauer, et al.
Frontiers in Immunology|March 3, 2020
Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 ImmunityRodrigo Jiménez-Saiz, Varun C Anipindi, Heather Galipeau, et al.
Frontiers in Pharmacology|August 8, 2022
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)M Karolyi, E Pawelka, S Omid, et al.
Science (New York, N.Y.)|January 5, 2019
Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreakL E Kafetzopoulou, S T Pullan, P Lemey, et al.
Pageof 12